Welcome to JDD Corner, your gateway to a world of dermatology knowledge and insights! JDD Corner is a curated collection of video abstracts, editor picks, Key Opinion Leader (KOL) spotlights, trending articles, and much more. Whether you are a dermatologist, a skincare enthusiast, or simply curious about the latest advancements in dermatology, JDD Corner is your one-stop destination for staying informed and up-to-date with the most exciting developments in the field. Explore our carefully selected content and immerse yourself in the dynamic world of dermatology. Welcome to JDD Corner!
JDD Corner
JDD Corner
Video Abstracts
Introducing an Exciting NEW Opportunity for Our Authors to Connect with Our Readership through a Cutting-Edge Media Channel! Email us at editorial@jddonline.com to get started!
NEW! VIDEO ABSTRACT
Structural Insights: What Makes Some IL-23 Biologics More Effective in Psoriasis
Understanding IL-23 Biologics
IL-23 biologics are designed to bind to specific regions (epitopes) on the p19 or p40 subunits, preventing IL-23 from activating its receptor and triggering the inflammatory cascade responsible for psoriasis.
NEW! VIDEO ABSTRACT
Pathophysiologic Targets for Acne Treatment
Acne vulgaris is an extremely common dermatologic condition. Individuals with acne present not only to dermatologists, but also to internists, family medicine physicians, pediatricians, estheticians, and beauty counters alike in search of a treatment. The diagnosis of acne is relatively straightforward, leading many to believe that acne is a simple condition.
NEW! VIDEO ABSTRACT
Efficacy and Tolerance of a Polymeric Surfactant Technology-Based Cleanser for Clinically Diagnosed Sensitive Skin
Cleansing is an important hygiene activity, necessary to prevent bacterial, fungal, yeast, and viral infection. However, in the presence of skin disease, cleansing can take on a new challenge: removing the sebum, sweat, externally applied substances, environmental debris, and organisms from the face without damaging the skin barrier.
VIDEO ABSTRACT
Image Analysis of Xerosis and Atopic Dermatitis Following Prebiotic Skincare Regimen in Ethnically Diverse Patients
Variations in the epidemiology, clinical presentation, and disease course in atopic dermatitis (AD) patients with Skin of Color (SOC) compared with white counterparts have been reported. In this study, we evaluated the capability of a new imaging device (SkinCam) in quantifying skin texture changes in diverse patients, presenting with AD or xerosis, after using a prebiotic skincare routine over 10 weeks.
VIDEO ABSTRACT
Patient- and Clinician-Reported Outcomes for Tirbanibulin in Actinic Keratosis in Clinical Practice Across the United States (PROAK)
The Patient-Reported Outcomes in Actinic Keratosis (PROAK) study evaluated patient- and clinician-reported outcomes (PRO; ClinRO) during 24 weeks of follow-up among adult patients with actinic keratosis (AK) on the face or scalp who were administered tirbanibulin 1% ointment in real-world community practices in the United States.
VIDEO ABSTRACT
The National Mentorship Match Algorithm: Mentors Needed
The National Mentorship Match Algorithm uses a novel, automated algorithm (Dr SAV) to pair dermatology residency applicants (mentees) with dermatology mentors based on distinct applicant needs and interests. The National Mentorship Match Algorithm prioritizes UIM dermatology residency applicants and/or those without home dermatology programs.
Author Spotlight
Deborah S. Sarnoff MD
JDD Editor-in-Chief
JDD Editor-in-Chief
The Journal of Drugs in Dermatology is proud to announce Deborah S. Sarnoff MD as our new Editor-in-Chief. Please check out her first announcement of all the latest updates at JDD.
Read More
Trending Articles
Pharmacological Complications in Ocular Dermatology - Review and Update
Many dermatologic medications have the potential to induce ocular complications. Traditional medications, including corticosteroids, retinoids, antibiotics, antihistamines, and immunosuppressants, have been associated with eye dryness, irritation, allergy, infection, atrophy, pigmentary changes, increased intraocular pressure, and impaired vision. Novel therapeutic agents such as biologics raise new concerns for ocular surface disease and conjunctivitis. Dermatologists should recognize these oculocutaneous side effects for appropriate decision-making, coordinating interdisciplinary care, and optimizing patient outcomes.
Read More
Injectable Minoxidil for Hair Loss Disorders: A Systematic Review
This systematic review demonstrates injectable minoxidil is an efficacious and safe treatment for androgenetic alopecia, with variable efficacy and safety for treating alopecia areata. Injectable minoxidil is a promising primary and adjunctive therapy for treating androgenetic alopecia clinically. Further translational research should explore how the pharmacokinetic and bioavailability of injectable minoxidil translates to clinical efficacy to establish the optimal dosing.
Read More
Metformin Use and Risk of Non-Melanoma Skin Cancer: A Propensity-Matched Case-Control Study
There is literature that suggests metformin may play a protective role against the development of non-melanoma skin cancers. Given the significant burden of disease non-melanoma skin cancers represent, the possibility of a widely available and generally well-tolerated medication such as metformin as part of the prevention and treatment ladder warrants further research.
Read More
Effective With Minimal Side Effects: A Novel Treatment Regimen for Acne Vulgaris Using Multifunctional Ingredients
In this study, a well formulated, cosmetically elegant active acne regimen was found to be highly effective and well tolerated when used by adult acne patients of diverse ethnicities. In addition, the regimen improved cosmetic aspects of the skin including PIH and PIE, which are important when treating adult acne sufferers.
Read More
Triple-Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Moderate-to-Severe Acne in Children and Adolescents
Topical clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% (CAB) gel is the only fixed-dose triple-combination approved for acne (indicated in patients 12 years and older). As topical acne treatment in pediatric patients may be complicated by tolerability and/or a perceived lack of efficacy, post hoc analyses were used to investigate efficacy/safety of CAB in children and adolescents.
Read More
Cutaneous Collagenous Vasculopathy Treated With Pulsed Dye Laser: A Case Series and Literature Review
Cutaneous collagenous vasculopathy (CCV) is an underreported cutaneous microangiopathy that primarily involves the lower extremities. Optimal treatment of CCV has not been well-defined, which may be in part due to the rare nature of the condition; however, a few case reports have demonstrated a reduction in the appearance of CCV-associated telangiectasias with vascular laser therapy. Here, we present two cases of CCV successfully treated with pulsed dye laser (PDL) therapy and summarize the existing literature on this topic.
Read More
Recent News
Editor's Picks
Video Pearls
Tough Day at the Office: Lupus, Sarcoidosis, and a Side of Morphea
Watch as Dr. Friedman shares basic principles to managing three distinct diseases – cutaneous lupus, sarcoidosis and linear morphea. Learn why you need to do a good review of organ systems and be prepared to phone a friend (or more) across the aisle in medicine.
Tips for Providing Better Atopic Dermatitis Care
With the growing list of therapeutic options, Dr. Friedman encourages clinicians to go back to the basics and address one of the greatest challenges — treatment adherence.
Acne and Diet
Adam Friedman, professor and chair of dermatology at GW School of Medicine and Health Sciences. Dr. Friedman says acne is an evidence-based example of the saying “you are what you eat.”
Crushing It In The Capital: Lessons From Residency Translated
Dr. Friedman provides his tips for remaining calm during the craziest of office visits. He also shares why being fun, creative and an off-label bandit matters.
New Innovations in Hyperpigmentation
Dr. Chilukuri outlines at-home and in-office treatments to address hyperpigmentation, including newly developed therapies.
